Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India

Globally efforts are underway to shorten the existing 6-month tuberculosis (TB) treatment regimen for drug-sensitive patients, which would be equally effective and safe. At present, there is a lack of evidence on the cost implications of a shorter 4-month TB regimen in India. This economic modeling...

Descripción completa

Detalles Bibliográficos
Autores principales: Muniyandi, Malaisamy, Karikalan, Nagarajan, Velayutham, Banurekha, Rajsekar, Kavitha, Padmapriyadarsini, Chandrasekaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607110/
https://www.ncbi.nlm.nih.gov/pubmed/36288029
http://dx.doi.org/10.3390/tropicalmed7100288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607110/
https://www.ncbi.nlm.nih.gov/pubmed/36288029
http://dx.doi.org/10.3390/tropicalmed7100288

Ejemplares similares